Ann Dermatol.  2016 Aug;28(4):522-523. 10.5021/ad.2016.28.4.522.

Palmoplantar Pustulosis Induced by both Adalimumab and Golimumab for Treatment of Ankylosing Spondylitis

Affiliations
  • 1Department of Dermatology, Inje University Busan Paik Hospital, Busan, Korea.
  • 2Department of Dermatology, Inje University Haeundae Paik Hospital, Busan, Korea. derma09@hanmail.net

Abstract

No abstract available.


MeSH Terms

Adalimumab*
Spondylitis, Ankylosing*
Adalimumab

Figure

  • Fig. 1 Erythematous scaly patch with pustules on both palms were seen.

  • Fig. 2 (A) Histopathologic findings of the lesion showed psoriasiform epidermal hyperplasia with perivascular inflammatory cell infiltration in the papillary dermis (H&E, ×40). (B) Parakeratosis and intraepidermal spongiform bullae filled with neutrophils was observed in expanded view (H&E, ×200).


Reference

1. Wendling D, Prati C. Paradoxical effects of anti-TNF-α agents in inflammatory diseases. Expert Rev Clin Immunol. 2014; 10:159–169.
Article
2. Smolen JS, Kay J, Doyle MK, Landewé RB, Matteson EL, Gaylis N, et al. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomized, double-blind, placebo-controlled, phase III trial. Lancet. 2009; 374:210–221.
Article
3. Collamer AN, Guerrero KT, Henning JS, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum. 2008; 59:996–1001.
Article
4. Ko JM, Gottlieb AB, Kerbleski JF. Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases. J Dermatolog Treat. 2009; 20:100–108.
Article
5. Nguyen K, Vleugels RA, Velez NF, Merola JF, Qureshi AA. Psoriasiform reactions to anti-tumor necrosis factor α therapy. J Clin Rheumatol. 2013; 19:377–381.
Article
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr